This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2013
Title: Venkateswarulu Akella: Innovator in Alzheimer's Disease Treatment
Introduction
Venkateswarulu Akella is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease. His innovative work focuses on the development of niacin compositions aimed at reducing the production of amyloid beta peptide 42, which is linked to neurodegenerative diseases.
Latest Patents
Venkateswarulu Akella holds a patent for "Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)." This invention discloses several key components, including phenolic ester hybrids of niacin with m-methoxy-p-hydroxy phenyl compounds such as eugenol, vanillin, apocynin, ferulic acid, isoferulic acid, and eugenol epoxide. Additionally, it includes cocrystals of these hybrids, particularly the cocrystal of niacin-eugenol hybrid with cocrystal formers like eugenol and oxalic acid. The patent also describes novel pharmaceutical compositions that combine niacin with small molecule potentiating agents like eugenol, curcumin, and cinnamic acid. These compositions are intended for treating disorders caused by excess production of amyloid beta peptide-42, including Alzheimer's disease, dementia, and other neurodegenerative conditions.
Career Highlights
Venkateswarulu Akella has demonstrated a strong commitment to research and innovation in the pharmaceutical industry. His work has the potential to significantly impact the treatment of Alzheimer's disease and improve the quality of life for patients suffering from this debilitating condition.
Collaborations
He collaborates with Uday Saxena, contributing to the advancement of research in the field of neurodegenerative diseases.
Conclusion
Venkateswarulu Akella's innovative contributions to Alzheimer's disease treatment through his patented niacin compositions highlight his dedication to addressing critical health challenges. His work exemplifies the importance of research and innovation in developing effective therapies for neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile